Rabies Diagnostic Market by Diagnostic method, Technology Region - Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2032

6.64%
CAGR (2026-2032)
2.2 USD Bn.
Market Size
312
Report Pages
165
Market Tables

Overview

Rabies Diagnostic Market was valued at US$ 2.20 Bn. in 2025 and the market size is expected to grow at a CAGR of 6.64 % through the forecast period.

Rabies Diagnostic Market Overview:

Rabies is a viral disease that can be prevented by avoiding contact with a rabid animal's bite. Rabies is a virus that attacks mammals' central nervous systems, leading to brain damage and death. Although any mammal can contract rabies, the great majority of rabies cases reported to the Centers for Disease Control and Prevention (CDC) each year involve wild animals such as bats, raccoons, skunks, and foxes. Nausea, vomiting, violent movements, uncontrollable excitement, dread of water, inability to move portions of the body, confusion, and loss of consciousness are some of the symptoms that rabies patients experience.

Global Rabies Diagnostic Market

To know about the Research Methodology :- Request Free Sample Report

The rabies virus can be detected in any section of the damaged brain, but the test must involve tissue from at least two places in the brain, preferably the brain stem and cerebellum, to rule out rabies. The animal must be put to sleep for the test.

The fluorescent antibody test for rabies in animals and humans is the most extensively used main diagnostic test (FAT). Doctors can identify rabies only by doing many tests on your blood, skin, spinal fluid, and saliva. This test is based on antigen detection and is considered as the gold standard for rabies diagnosis by both the WHO and the OIE.

The report explores the Rabies Diagnostics Market's segments (Connectivity and Content, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2021. The report investigates the Rabies Diagnostics Market's drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Rabies Diagnostics Market's contemporary competitive scenario

Global Rabies Diagnostic Market Dynamics:

The rising frequency of infectious animal-transmitted diseases such as rabies and neglected tropical diseases, as well as increased awareness initiatives about infectious diseases and the expanding number of rabies diagnostic tests, are the most important factors impacting global market growth.

Excess salivation, headaches, fevers, muscle spasms, and mental instability are all signs of rabies, an infectious disease spread via animal bite or saliva. Fluorescent Antibody Test (FAT), immunohistochemistry tests, and amplification procedures are among the most well-known rabies diagnostic methods. Antigens of the rabies virus can be detected in brain tissue quickly and accurately with these procedures.
Rising cases of dog bites will support positively the growth of the Rabies diagnostics market.

Nowadays, the government is also taking many initiatives and creating laws associated with the diagnosis of rabies which will further be projected to fuel the market growth and Increase in demand for rabies diagnostic test in the healthcare industry gives rise to growth opportunities for manufacturers. Government initiatives further provide a platform for participants to capitalize on the opportunities. Governments, especially in developed countries, have increased funding for R&D initiatives for the development of novel technologies.

Rabies Diagnostic Market Segment Analysis:

Based on Diagnostic Method

Based on the diagnostic method market is segmented into Fluorescent Antibody Test (FAT), Immunohistochemical test, Amplification methods, Histologic examination and Serology tests.

The FAT technique has been dominated the market in historical period and is expected to continue the trend in the forecast period and it is used for the detection of rabies virus in brain tissue

Immunohistochemical test have a second largest share market share in the rabies diagnostic and it is used to help diagnose diseases, such as rabies and cancer.
Serology tests detect the presence of antibodies in the blood from the body's adaptive immune response to an infection like rabies virus.

Based on the Technology

Based on technology market is segmented into ELISA, Chromatography techniques, PCR and Others.ELISA stands for enzyme-linked immunoassay dominated the market in historical period and is expected to continue the trend in the forecast period. It is a commonly used laboratory test to detect antibodies in the blood.PCR means polymerase chain reaction and it is a test to detect genetic material from a specific organism, such as a virus.

Global Rabies Diagnostic Market Regional Insights:

The North America rabies diagnostics market led in terms of market revenue share in the historical period. Market growth in North America is accelerated by rising prevalence of rabies and other animal-transmitted diseases, growing number of rabies diagnostic tests, increased healthcare expenditures, and advanced healthcare infrastructure in the region.

The market in Asia-Pacific is predicted to grow at the quickest rate during the forecast period, increased public awareness of healthcare, an increase in the number of hospitals and diagnosis clinics, and increased government spending in the healthcare sector are all contributing to the growing usage of rabies diagnostic test In the Asia-Pacific area, the prevalence of spreading infectious diseases, as well as an increase in healthcare spending, are boosting growth.

Global Rabies Diagnostic Market Scope: Inquire before buying

Global Rabies Diagnostic Market
Report Coverage Details
Base Year: 2025 Forecast Period: 2026-2032
Historical Data: 2020 to 2025 Market Size in 2025: 2.20 USD Billion
Forecast Period 2026-2032 CAGR: 6.64% Market Size in 2032: 3.45 USD Billion
Segments Covered: by Technology ELISA
Chromatography techniques
PCR
Others
by Diagnostic method Fluorescent Antibody Test (FAT)
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
by Sample Type Brain tissue
Saliva
Cerebrospinal fluid (CSF)
Blood (Serum)
Others
by End-Use Hospitals
Diagnostic Centers
Cancer Palliative Care Clinics
Others

Rabies Diagnostic Market by Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa

Rabies Diagnostic Market Key Players

  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Agilent Technologies Inc.
  • Aviva Systems Biology Corporation
  • Demeditec Diagnostics GmbH
  • Creative Diagnostics
  • Norgen Biotek Corp.
  • BioNote, Inc.
  • Express Biotech International Inc.
  • MyBioSource Inc.
  • IDEXX Laboratories Inc.
  • Neogen Corporation
  • Randox Laboratories Ltd.
  • SDIX LLC
  • Sigma-Aldrich Corporation
  • Bio-X Diagnostics S.A.
  • Fujirebio Diagnostics Inc.
  • Gold Standard Diagnostics Corp.
  • Heska Corporation
  • InBios International Inc.
  • Shanghai Kehua Bio-Engineering Co., Ltd.
  • Meridian Bioscience Inc.
  • MP Biomedicals LLC
  • Zoetis Inc.
  • Abcam plc
  • Vetoquinol S.A.
  • Virbac

Frequently Asked Questions:

1] What segments are covered in the Global Rabies Diagnostic Market report?
Ans. The segments covered in the Market report are based on Diagnostic method and Technology.

2] Which region is expected to hold the highest share in the Global Rabies Diagnostic Market?
Ans. North America region is expected to hold the highest share in the Market.

3] What is the market size of the Global Rabies Diagnostic Market by 2032?
Ans. The market size of the Market by 2032 is expected to reach US$ 3.45 Bn.

4] What is the forecast period for the Global Rabies Diagnostic Market?
Ans. The forecast period for the market is 2026-2032.

5] What was the market size of the Global Rabies Diagnostic Market in 2025?
Ans. The market size of the Rabies Diagnostic Market in 2025 was valued at US$ 2.20 Bn.

Table of Contents

1. Global Rabies Diagnostic Market: Research Methodology 2. Global Rabies Diagnostic Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Rabies Diagnostic Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Rabies Diagnostic Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Rabies Diagnostic Market Segmentation 4.1 Global Rabies Diagnostic Market, By Diagnostic method (2025-2032) • Fluorescent Antibody Test (FAT) • Immunohistochemical test • Amplification methods • Histologic examination • Serology tests 4.2 Global Rabies Diagnostic Market, By Technology (2025-2032) • ELISA • Chromatography techniques • PCR • Blood (Serum) • Others 4.3 Global Rabies Diagnostic Market, By Technology (2025-2032) • Brain tissue • Saliva • Cerebrospinal fluid (CSF) • Others 4.4 Global Rabies Diagnostic Market, By Technology (2025-2032) • Hospitals • Diagnostic Centers • Cancer Palliative Care Clinics • Others 5. North America Rabies Diagnostic Market (2025-2032) 5.1 North America Rabies Diagnostic Market, By Diagnostic method (2025-2032) • Fluorescent Antibody Test (FAT) • Immunohistochemical test • Amplification methods • Histologic examination • Serology tests 5.2 North America Rabies Diagnostic Market, By Technology (2025-2032) • ELISA/Immunohistochemistry • Chromatography techniques • PCR • Others 5.3 Global Rabies Diagnostic Market, By Technology (2025-2032) • Brain tissue • Saliva • Cerebrospinal fluid (CSF) • Others 5.4 Global Rabies Diagnostic Market, By Technology (2025-2032) • Hospitals • Diagnostic Centers • Cancer Palliative Care Clinics • Others 5.5 North America Rabies Diagnostic Market, by Country (2025-2032) • United States • Canada • Mexico 6. Asia Pacific Rabies Diagnostic Market (2025-2032)(Note:All segmentation in the global market are also included ) 6.1. Asia Pacific Rabies Diagnostic Market, By Diagnostic method (2025-2032) 6.2. Asia Pacific Rabies Diagnostic Market, By Technology (2025-2032) 6.3. Asia Pacific Rabies Diagnostic Market, by Country (2025-2032) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Rabies Diagnostic Market (2025-2032)(Note:All segmentations in the global market are also included ) 7.1 Middle East and Africa Rabies Diagnostic Market, By Diagnostic method (2025-2032) 7.2. Middle East and Africa Rabies Diagnostic Market, By Technology (2025-2032) 7.3. Middle East and Africa Rabies Diagnostic Market, by Country (2025-2032) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Rabies Diagnostic Market (2025-2032)(Note:All segmentation in the global market are also included ) 8.1. Latin America Rabies Diagnostic Market, By Diagnostic method (2025-2032) 8.2. Latin America Rabies Diagnostic Market, By Technology (2025-2032) 8.3. Latin America Rabies Diagnostic Market, by Country (2025-2032) • Brazil • Argentina • Rest of Latin America 9. European Rabies Diagnostic Market (2025-2032)(Note:All segmentations in the global market are also included ) 9.1. European Rabies Diagnostic Market, By Diagnostic method (2025-2032) 9.2. European Rabies Diagnostic Market, By Technology (2025-2032) 9.3. European Rabies Diagnostic Market, by Country (2025-2032) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest of Europe 10. Company Profile: Key players 10.1 Bio-Rad Laboratories, Inc. 10.2 Merck KGaA 10.3 Thermo Fisher Scientific Inc. 10.4 Hoffmann-La Roche Ltd. 10.5 QIAGEN N.V. 10.6 Agilent Technologies Inc. 10.7 Aviva Systems Biology Corporation 10.8 Demeditec Diagnostics GmbH 10.9 Creative Diagnostics 10.10 Norgen Biotek Corp. 10.11 BioNote, Inc. 10.12 Express Biotech International Inc. 10.13 MyBioSource Inc. 10.14 IDEXX Laboratories Inc. 10.15 Neogen Corporation 10.16 Randox Laboratories Ltd. 10.17 SDIX LLC 10.18 Sigma-Aldrich Corporation 10.19 Bio-X Diagnostics S.A. 10.20 Fujirebio Diagnostics Inc. 10.21 Gold Standard Diagnostics Corp. 10.22 Heska Corporation 10.23 InBios International Inc. 10.24 Shanghai Kehua Bio-Engineering Co., Ltd. 10.25 Meridian Bioscience Inc. 10.26 MP Biomedicals LLC 10.27 Zoetis Inc. 10.28 Abcam plc 10.29 Vetoquinol S.A. 10.30 Virbac

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements